Valerion
  • Home
  • About US
    • Who We Are
    • Our Leadership
    • Partners & Investors
    • Company History
  • Technology
    • Overview
    • Pipeline
    • Pompe Disease
    • Lafora disease
    • Myotubular Myopathy
  • News
  • Patients
    • Patients Updates
  • CONTACT

Month: February 2018

Feb 2018

A Natural History Study of X-Linked Mytotubular Myopathy

MTM-Dowling NHS amburgey-2017READ MORE...

Feb 2018

Poster Presentation at WORLDS Symposium

Valerion to Present Initial Clinical Data with VAL-1221 in Pompe DiseaseREAD MORE...

Recent Posts

  • Advances in Neurodegenerative Disease Research and Therapy
  • A Natural History Study of X-Linked Mytotubular Myopathy
  • Poster Presentation at WORLDS Symposium
  • Valerion Presents Preclinical Proof-of-Concept Data for VAL-0417 for the Treatment of Lafora Disease
  • Novel approaches to improved treatments for orphan genetic diseases: Enhanced intracellular delivery of protein therapy through natural transport mechanisms

Recent Comments

    Archives

    • June 2018
    • February 2018
    • September 2017
    • August 2017
    • July 2017
    • April 2017
    • March 2017
    • September 2015
    • December 2014
    • June 2013
    • April 2013
    • March 2012

    Categories

    • News
    • Uncategorized

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org

    ©2019 Valerion Therapeutics. All Rights Reserved.

    100 Main St., Suite 110
    Concord, MA 01742